Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Protein kinase domain containing protein | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Fps85D | 0.0824 | 0.5 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Fgr | 0.0824 | 0.5 | 0.5 |
Brugia malayi | protein-tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Brugia malayi | SH2 domain containing protein | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase ABL1 | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | c src tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0824 | 0.5 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase ABL1 | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase shark | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Blk | 0.0824 | 0.5 | 0.5 |
Entamoeba histolytica | SH2-protein kinase domain containing protein | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Abl | 0.0824 | 0.5 | 0.5 |
Schistosoma mansoni | proto-oncogene tyrosine-protein kinase src | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0824 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0824 | 0.5 | 0.5 | |
Echinococcus granulosus | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Src64B | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine kinase|tyrosine protein kinase Fyn | 0.0824 | 0.5 | 0.5 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Src64B | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Fps85D | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase lyn tyrosine protein kinase blk | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0824 | 0.5 | 0.5 |
Brugia malayi | SH2 domain containing protein | 0.0824 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0824 | 0.5 | 0.5 | |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase lyn lyn a protein tyrosine kinase lymphocyte specific protein tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Brugia malayi | SRC-1 | 0.0824 | 0.5 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Srms | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | SRC-1 | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Src42A | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/ABL protein kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | proto oncogene tyrosine protein kinase LCK | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Src42A | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0824 | 0.5 | 0.5 |
Brugia malayi | hypothetical protein | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | 3'partial|tyrosine protein kinase Fgr | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase Btk29A | 0.0824 | 0.5 | 0.5 |
Echinococcus multilocularis | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0824 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0824 | 0.5 | 0.5 | |
Schistosoma mansoni | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0824 | 0.5 | 0.5 | |
Echinococcus granulosus | tyrosine protein kinase shark | 0.0824 | 0.5 | 0.5 |
Loa Loa (eye worm) | TK protein kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | c src tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | proto oncogene tyrosine protein kinase LCK | 0.0824 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0824 | 0.5 | 0.5 | |
Echinococcus multilocularis | tyrosine protein kinase Srms | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine kinase | 0.0824 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0824 | 0.5 | 0.5 | |
Echinococcus multilocularis | tyrosine protein kinase Blk | 0.0824 | 0.5 | 0.5 |
Echinococcus granulosus | tyrosine protein kinase Btk29A | 0.0824 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -6.19 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.417 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.792 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.788 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.769 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.752 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.748 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.747 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.722 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.719 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.714 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.